证券代码：603379 证券简称：三美股份 公告编号：2023-034 浙江三美化工股份有限公司 第六届监事会第五次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 浙江三美化工股份有限公司（以下简称"公司"）于 2023 年 8 月 10 日以现场 表决方式在公司会议室召开第六届监事会第五次会议。会议通知已于 2023 年 8 月 4 日以书面、电子邮件等方式向全体监事发出。本次会议应出席监事 3 人，实 际出席监事 3 人。监事会主席陈侃主持会议，董事会秘书列席会议。本次会议召 开符合《公司法》和《公司章程》的有关规定。 经与会监事审议，本次会议以投票表决的方式审议通过了以下议案： 一、审议通过《关于增加 2023 年度日常关联交易额度的议案》 2023 年 8 月 10 日 内容详见 2023 年 8 月 10 日公司在上海证券交易所网站 www.sse.com.cn 以 及 2023 年 8 月 11 日在《上海证券报》披露的《浙江三美化工股份有限公司关于 增加 2023 年度日常关联交易额度的公告》。 监 ...

关于三美股份股票交易异常波动有关情况的回函 浙江三美化工股份有限公司： 本人于 2023 年 8 月 9 日收到贵公司发来的《关于三美股份股票交易异常波 动的询证函》。经本人自查确认，回复如下： 本人作为浙江三美化工股份有限公司（以下简称"三美股份"或"公司"）的实 际控制人，截至目前，不存在影响公司股票交易异常波动的重大事项，不存在应 披露而未披露的重大信息，包括但不限于涉及上市公司的重大资产重组、股份发 行、收购、债务重组、业务重组、资产剥离、资产注入、股份回购、股权激励、 破产重整、重大业务合作、引进战略投资者等重大事项。在三美股份异常波动期 间，本人及一致行动人不存在买卖公司股票的情况。 特此回复。 胡淇翔 2023 年 8 月 9 日 本人于 2023 年 8 月 9 日收到贵公司发来的《关于三美股份股票交易异常波 动的询证函》。经本人自查确认，回复如下： 本人作为浙江三美化工股份有限公司（以下简称"三美股份"或"公司"）的控 股股东、实际控制人，截至目前，不存在影响公司股票交易异常波动的重大事项， 不存在应披露而未披露的重大信息，包括但不限于涉及上市公司的重大资产重组、 股份发行、收购、债务重组、 ...

证券代码：603379 证券简称：三美股份 公告编号：2023-032 浙江三美化工股份有限公司 股票交易异常波动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司股票于 2023 年 8 月 7 日、8 日、9 日连续 3 个交易日内收盘价格涨 幅偏离值累计达到 20%，根据《上海证券交易所交易规则》的有关规定，属于股 票交易异常波动的情形。 经公司自查，并向控股股东、实际控制人及其一致行动人书面问询，截 至本公告发布之日，公司确认不存在应披露而未披露的重大信息。 8 月 9 日下午，国家生态环境部大气环境司组织召开了《2024 年度全国 HFCs 配额总量设定与分配实施方案》（初稿）行业交流会。 本次会议仅为初稿的交流，《2024 年度全国 HFCs 配额总量设定与分配实施 方案》尚存在不确定性，具体落地方案，请以国家有关监管部门正式颁布为准。 敬请广大投资者注意投资风险，理性决策，审慎投资。 相关风险提示：2023 年 8 月 9 日，公司股票收盘价 31.60 元/股，动态市 盈率为 241.5 ...

Financial Performance - The company's operating revenue for Q1 2023 was RMB 777,604,061.17, a decrease of 34.12% compared to the same period last year[4] - The net profit attributable to shareholders was RMB 19,972,241.76, down 89.65% year-on-year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses was RMB 21,718,081.36, a decline of 87.66% compared to the previous year[4] - The basic earnings per share were RMB 0.03, reflecting a decrease of 90.63% year-on-year[4] - Total operating revenue for Q1 2023 was RMB 777.60 million, a decrease of 34% compared to RMB 1,180.42 million in Q1 2022[16] - Net profit for Q1 2023 was RMB 19.97 million, a significant decline of 90.6% from RMB 192.99 million in Q1 2022[17] - Total profit for Q1 2023 was RMB 26.11 million, down 89.8% from RMB 254.98 million in Q1 2022[17] Assets and Liabilities - Total assets at the end of the reporting period were RMB 6,286,080,232.07, down 2.23% from the end of the previous year[5] - The company's current assets totaled RMB 4,524,933,632.09, down from RMB 4,733,362,572.34, indicating a decrease of about 4.41%[12] - Total liabilities decreased to RMB 548,846,911.08 from RMB 720,106,748.11, a significant decline of approximately 23.8%[14] - The company's equity attributable to shareholders increased to RMB 5,737,233,320.99 from RMB 5,709,667,982.73, reflecting a slight increase of about 0.48%[15] Cash Flow - The company reported a net cash flow from operating activities of RMB 222,854,466.72, a decrease of 5.99% year-on-year[4] - Cash inflow from operating activities in Q1 2023 was RMB 782.22 million, down 31% from RMB 1,136.71 million in Q1 2022[19] - The net cash flow from operating activities was $222,854,466.72, a decrease of 6.1% compared to $237,046,946.14 in the previous period[20] - Cash outflow from operating activities totaled $559,365,928.72, down from $899,663,946.89, indicating a significant reduction in operational cash expenses[20] - The total cash and cash equivalents at the end of the period reached $3,622,900,826.13, an increase from $2,037,320,323.71, showing strong liquidity position[20] Operational Metrics - The decline in revenue and profit was primarily due to a decrease in both sales volume and sales prices[7] - The weighted average return on equity was 0.35%, a decrease of 3.23 percentage points compared to the previous year[4] - Research and development expenses increased to RMB 8.82 million in Q1 2023, up 36% from RMB 6.49 million in Q1 2022[16] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 16,810[9] Other Financial Activities - The company reported a foreign currency translation loss of RMB 110.88 in Q1 2023, compared to a loss of RMB 873.80 in Q1 2022[18] - Investment loss for Q1 2023 was RMB 1.86 million, compared to a gain of RMB 2.60 million in Q1 2022[17] - Other income for Q1 2023 was RMB 1.27 million, a decrease of 48.7% from RMB 2.48 million in Q1 2022[17] - The company has not participated in margin financing or securities lending activities during the reporting period[10] - There are no significant new product developments or market expansion strategies mentioned in the report[11]

Financial Performance - The company's operating revenue for 2022 was approximately ¥4.77 billion, representing a year-over-year increase of 17.84% compared to ¥4.05 billion in 2021[16]. - The net profit attributable to shareholders for 2022 was approximately ¥485.57 million, a decrease of 9.44% from ¥536.17 million in 2021[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥451.10 million, down 6.79% from ¥483.98 million in 2021[16]. - The net cash flow from operating activities for 2022 was approximately ¥628.73 million, an increase of 158.22% compared to ¥243.49 million in 2021[16]. - The total assets at the end of 2022 were approximately ¥6.43 billion, reflecting a 6.26% increase from ¥6.05 billion at the end of 2021[16]. - The net assets attributable to shareholders at the end of 2022 were approximately ¥5.71 billion, up 7.97% from ¥5.29 billion at the end of 2021[16]. - The weighted average return on equity decreased by 1.46 percentage points to 8.84%[1]. - The company reported a basic earnings per share of CNY 0.80, down 9.09% from CNY 0.88 in the previous year[1]. Dividend Policy - The company plans to distribute a cash dividend of 2.39 CNY per 10 shares, totaling approximately 145.90 million CNY (including tax) based on a total share capital of 610,479,037 shares as of December 31, 2022[2]. - The company has established a cash dividend policy, stating that the total cash dividends should not be less than 20% of the audited net profit attributable to shareholders in the current year[156]. - The cash dividend represents 19.36% of the net profit attributable to ordinary shareholders in the consolidated financial statements, which amounted to 536,168,573.50 RMB[161]. - The total dividend amount, including cash buybacks, is 268,605,244.78 RMB, accounting for 50.10% of the net profit attributable to ordinary shareholders[161]. - The company maintains a cash dividend policy where at least 40% of profits are distributed as cash dividends during the mature stage of development with significant capital expenditures[157]. - The company has not made any adjustments to its profit distribution policy during the reporting period[158]. Corporate Governance - The company has established a robust governance structure, holding three shareholder meetings during the reporting period to ensure transparency and protect shareholder rights[122]. - The company held 6 board meetings during the reporting period, with 9 current directors, including 3 independent directors, ensuring compliance with legal regulations[123]. - The company established a comprehensive performance evaluation system for senior management, linking compensation closely to performance, with core management holding shares in the company[125]. - The company maintained strict independence from its controlling shareholders and related parties in personnel, assets, finance, and operations, ensuring independent accounting and risk management[126]. - The company engaged in effective communication with investors through various channels, ensuring fair treatment of institutional and retail investors[126]. - The company emphasized environmental protection and social responsibility, increasing investment in environmental governance and supporting community welfare initiatives[126]. Risk Management - The company has outlined potential risks and corresponding countermeasures in the report, particularly in the section discussing future development[4]. - The company is addressing cyclical industry risks by closely monitoring macroeconomic conditions and downstream market demands, which significantly impact the fluorochemical sector[116]. - The company is facing a cyclical downturn in the fluorochemical industry, primarily due to oversupply and price declines[111]. - The company anticipates that the supply-demand relationship will improve as HFCs quota policies are implemented and industry capacity contracts during the downturn[111]. - The company is monitoring foreign exchange risks related to its export activities and will utilize financial instruments like forward contracts to mitigate these risks[120]. Environmental and Social Responsibility - The company invested 13.8011 million yuan in environmental protection during the reporting period[168]. - The total emissions of nitrogen oxides were 3.6193 tons, with a concentration of 11.627 mg/m³, well below the standard of 35 mg/m³[169]. - The total emissions of sulfur dioxide were 0.8513 tons, with a concentration of 2.683 mg/m³, below the standard of 50 mg/m³[169]. - The company has established an environmental protection mechanism and is classified as a key pollutant discharge unit[168]. - The company has implemented emergency response plans for environmental incidents, including comprehensive and specialized plans for hazardous chemical accidents and flood prevention[174]. - The company invested 2.8578 million yuan in social responsibility initiatives, benefiting 4,526 individuals through various charitable activities[183]. Research and Development - The company has invested in 28 R&D projects focusing on optimizing production processes and developing new products, including environmentally friendly refrigerants and fine chemicals[87]. - The company holds 96 authorized patents and has 43 pending patent applications, primarily in the fields of production processes and environmental technologies[87]. - Research and development expenses rose by 42.82% to CNY 38,310,662.41, reflecting increased investment in R&D projects[48]. Production Capacity and Operations - The company has a production capacity of 131,000 tons for anhydrous hydrofluoric acid (AHF), which helps in managing costs and enhancing profitability[26]. - The company has a production capacity of 65,000 tons for HFC-134a, 52,000 tons for HFC-125, 40,000 tons for HFC-32, and 10,000 tons for HFC-143a, making HFCs refrigerants the company's primary product[41]. - The company has a production capacity of 14,400 tons for HCFC-22, with 11,800 tons allocated for refrigerant production, accounting for 5.25% of the national production quota[37]. - The company has a production capacity of 35,600 tons for HCFC-141b, with 28,000 tons allocated for foaming agent production, representing 55.05% of the national production quota[38]. - The company is expanding AHF production capacity from 31,000 tons to 90,000 tons through ongoing projects[97]. Market Position and Strategy - The company is focusing on the integration of the industrial chain with investments in fluorinated refrigerants, fine chemicals, and polymers to foster new growth points[32]. - The company aims to become a leading manufacturer of refrigerants and fluorinated chemicals, with a focus on HFCs and fluoropolymer products[112]. - The company is committed to maintaining its market position in HFCs refrigerants while developing new environmentally friendly refrigerants and expanding into high-value products like fluoropolymers and fine chemicals[117]. Shareholder Engagement - The company ensures that minority shareholders have sufficient opportunities to express their opinions and that their legal rights are fully protected[159]. - The independent directors have fulfilled their responsibilities and played a significant role in the decision-making process regarding profit distribution[159]. - The company has committed to repurchase all newly issued shares within 3 trading days if any false statements or omissions are identified in the prospectus, with the repurchase price being the lower of the market price or the issuance price[194].

浙江三美化工股份有限公司 关于召开 2022 年度业绩说明会的公告 证券代码：603379 证券简称：三美股份 公告编号：2023-023 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 浙江三美化工股份有限公司（以下简称"公司"）于 2023 年 4 月 21 日发布 公司 2022 年年度报告，为便于广大投资者更全面深入地了解公司 2022 年度经营 成果、财务状况，公司计划于 2023 年 5 月 4 日下午 15:00-16:00 举行 2022 年度 业绩说明会，就投资者关心的问题进行交流。 一、说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2022 年度的经营成果 及财务指标的具体情况与投资者进行互动交流和沟通，在信息披露允许的范围内 就投资者普遍关注的问题进行回答。 二、说明会召开的时间、地点 会议召开时间：2023 年 05 月 04 日（星期四）下午 15:00-16:00 会 议 召 开 地 点 ： 上 海 证 券 交 易 所 上 证 路 演 中 心 （ 网 址 ： http: ...

Financial Performance - The company's operating revenue for Q3 2022 was CNY 1,199,272,857.41, representing a year-on-year increase of 23.54%[4] - The net profit attributable to shareholders for the same period was CNY 117,708,982.93, up 15.98% compared to the previous year[4] - The net profit attributable to shareholders after deducting non-recurring gains and losses increased by 33.66% year-on-year, totaling CNY 116,987,682.07[4] - Total operating revenue for the first three quarters of 2022 reached ¥3,768,143,775.51, a significant increase of 37.5% compared to ¥2,738,821,996.93 in the same period of 2021[15] - Net profit for Q3 2022 was ¥461,728,475.61, representing a 90.0% increase from ¥242,980,284.85 in Q3 2021[16] - Total comprehensive income for Q3 2022 was ¥461,725,746.66, compared to ¥242,960,295.82 in Q3 2021, reflecting strong growth[17] Earnings and Shareholder Information - The basic earnings per share for the year-to-date period was CNY 0.76, reflecting a 90.00% increase year-on-year[4] - Basic and diluted earnings per share for Q3 2022 were both ¥0.76, up from ¥0.40 in Q3 2021[17] - The company reported a total of 21,390 common shareholders at the end of the reporting period[9] - The top shareholder, Hu Rongda, holds 37.83% of the shares, totaling 230,913,959 shares[9] Assets and Liabilities - The total assets at the end of the reporting period reached CNY 6,414,603,121.92, a 6.01% increase from the end of the previous year[5] - As of September 30, 2022, the company's total assets amounted to RMB 6,414,603,121.92, an increase from RMB 6,051,148,356.58 at the end of 2021, reflecting a growth of approximately 6%[12][14] - The company's total liabilities decreased to RMB 736,128,958.99 from RMB 762,777,536.01, showing a reduction of about 3.5%[14] - The total equity attributable to shareholders increased to RMB 5,678,474,162.93 from RMB 5,288,370,820.57, marking an increase of approximately 7.4%[14] Cash Flow - The net cash flow from operating activities for the year-to-date period increased by 169.44% year-on-year, amounting to CNY 598,794,811.41[4] - Cash flow from operating activities for the first three quarters of 2022 was ¥2,921,995,958.27, up 54.8% from ¥1,887,278,295.71 in the same period of 2021[18] - Net cash flow from operating activities in Q3 2022 was ¥598,794,811.41, a substantial increase from ¥222,239,854.47 in Q3 2021[19] - The company reported a net cash inflow from investment activities of ¥1,158,965,137.97 in Q3 2022, a turnaround from a net outflow of -¥1,199,188,025.73 in Q3 2021[19] Costs and Expenses - Total operating costs for the first three quarters of 2022 were ¥3,170,178,937.53, up 32.2% from ¥2,398,628,857.26 in the first three quarters of 2021[15] - R&D expenses in Q3 2022 amounted to ¥26,314,646.13, an increase of 32.0% compared to ¥19,955,443.97 in Q3 2021[16] - The company’s tax expenses for Q3 2022 were ¥150,632,648.64, compared to ¥86,940,021.07 in Q3 2021, indicating increased profitability[16] Inventory and Receivables - Accounts receivable decreased to RMB 441,733,243.32 from RMB 636,633,697.92, representing a decline of approximately 31%[12] - The company's inventory decreased to RMB 453,491,649.59 from RMB 502,806,589.86, reflecting a decline of about 9.8%[12] - The company reported a significant reduction in other receivables, which fell to RMB 23,939,032.96 from RMB 64,907,016.88, a decrease of approximately 63%[12] Cash and Cash Equivalents - The company's cash and cash equivalents reached RMB 3,400,122,437.60, significantly up from RMB 1,612,620,164.27 in the previous year, indicating an increase of about 110%[12] - The total cash and cash equivalents increased by $1,803,425,273.33, compared to a decrease of $1,051,682,863.04 in the prior year[20] - The ending balance of cash and cash equivalents reached $3,371,162,437.60, up from $1,432,451,656.62 in the previous period[20] - The impact of exchange rate changes on cash and cash equivalents was $67,604,002.20, contrasting with -$7,581,997.71 in the prior year[20]

Financial Performance - The company reported a total revenue of 1.2 billion CNY for the first half of 2022, representing a year-on-year increase of 15%[1]. - The company's operating revenue for the first half of 2022 was CNY 2,568,870,918.10, representing a year-on-year increase of 45.29%[16]. - The net profit attributable to shareholders for the same period was CNY 344,019,492.68, a significant increase of 143.14% compared to the previous year[16]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 318,209,142.40, reflecting a year-on-year growth of 119.25%[16]. - The net cash flow from operating activities increased by 317.97% to CNY 354,319,812.09, primarily due to increased cash received from sales of goods and services[18]. - Basic earnings per share for the first half of 2022 were CNY 0.57, a 147.83% increase from CNY 0.23 in the same period last year[17]. - The company's total comprehensive income for the first half of 2022 was approximately ¥332.80 million, compared to ¥89.75 million in the same period of 2021[123]. - The company's financial expenses showed a significant increase, with a net financial cost of approximately -¥64.52 million in the first half of 2022, compared to -¥2.25 million in the same period of 2021[122]. Market Expansion and Strategy - The company plans to expand its market presence in Southeast Asia, targeting a 25% market share by the end of 2023[1]. - New product launches are expected to contribute an additional 200 million CNY in revenue by Q4 2022[1]. - The company is focusing on expanding its production capacity and market presence in response to the growing demand for fluorinated chemicals in various industries[24]. - The company is considering strategic acquisitions to bolster its competitive position, with potential targets identified in the tech sector[91]. - A new marketing strategy is being implemented, aiming to improve customer engagement and retention by 25%[91]. Research and Development - Research and development expenses increased by 30% to 150 million CNY, focusing on innovative chemical products[1]. - Research and development investments increased by 40%, focusing on innovative technologies to enhance product offerings[91]. - The company holds 81 authorized patents and has 52 patent applications pending, focusing on new refrigerants and fine chemical products[43]. Sustainability and Environmental Commitment - The company has committed to sustainability initiatives, aiming for a 50% reduction in carbon emissions by 2025[1]. - The company is committed to green production and has implemented energy-saving management plans to eliminate high-energy-consuming equipment[82]. - The company has implemented energy-saving measures, including the use of high-efficiency materials and advanced control systems, to further reduce energy consumption and carbon emissions[82]. - The company has established a comprehensive safety management system and emergency response teams to mitigate safety and environmental risks associated with its operations[56]. Risks and Challenges - The management highlighted potential risks including raw material price fluctuations and regulatory changes impacting operations[1]. - The company is sensitive to product price fluctuations, and ongoing supply-demand imbalances may lead to sustained price declines, adversely affecting performance[58]. - The company has faced trade protectionism challenges, with investigations initiated by the US, India, and Argentina against its HFC refrigerants, posing risks to its export operations[61]. Shareholder and Financial Management - The company has implemented an employee stock ownership plan, with 6.58 million shares transferred at a price of 12.53 CNY per share[67]. - The company plans to implement a stock buyback program, purchasing shares at a price not exceeding the audited net asset value per share from the previous fiscal year[92]. - The company commits to a cash dividend to all shareholders, not exceeding 20% of the previous year's audited net profit attributable to shareholders, if stock price stabilization measures are not taken[86]. - The company has established a long-term commitment to maintaining compliance with stock distribution requirements post-repurchase[90]. Production Capacity and Product Offerings - The production capacity for HFCs refrigerants includes 65,000 tons for HFC-134a, 52,000 tons for HFC-125, 40,000 tons for HFC-32, and 10,000 tons for HFC-143a, making HFCs the company's primary product[25]. - The company has a production capacity of 131,000 tons for anhydrous hydrofluoric acid (AHF), which is essential for the production of fluorinated refrigerants and other fluorine-based products[27]. - The company’s AHF production capacity utilization rate remains high, providing a cost advantage as AHF accounts for approximately 30% of the production cost of fluorinated refrigerants[34]. Compliance and Governance - The financial statements were approved by the board of directors on August 24, 2022[138]. - The company has not reported any violations or penalties involving its directors, supervisors, senior management, or controlling shareholders during the reporting period[96]. - The company has not engaged in any non-operating fund occupation by controlling shareholders or related parties during the reporting period[95]. Economic and Industry Context - The overall industrial added value in China grew by 3.4% year-on-year in the first half of 2022, indicating a recovery in the economy[22]. - The company operates in the fluorochemical industry, which is cyclical and closely related to macroeconomic factors and the demand from downstream industries such as real estate, air conditioning, refrigeration, and automotive[57].

Dividend Distribution - The company plans to distribute a cash dividend of 1.70 CNY per 10 shares, totaling approximately 103.78 million CNY based on a total share capital of 610,479,037 shares as of December 31, 2021[4]. - The company has no plans for capital reserve transfers to increase share capital in the current dividend distribution proposal[4]. - The company plans to distribute cash dividends of 1.10 CNY per 10 shares, totaling approximately 67.15 million CNY based on a total share count of 610,479,037 shares as of December 31, 2020[199]. - The cash dividend policy stipulates that the total cash dividends should not be less than 20% of the audited net profit attributable to shareholders of the listed company for the year[194]. - In the case of a mature company without significant capital expenditure, the cash dividend proportion should be at least 80% of the profit distribution[195]. - The company emphasizes the importance of reasonable returns to investors while ensuring sustainable development[194]. - The company will consider cash or stock dividends, with a preference for cash[194]. - The board of directors must propose the profit distribution plan, which requires approval from more than half of the directors[197]. - The company retains undistributed profits primarily for investments related to business operations, asset purchases, and enhancing R&D capabilities[197]. - The company will communicate with shareholders, especially minority shareholders, to gather opinions on profit distribution plans[197]. - The company’s profit distribution policy can be adjusted if there are significant changes in the operating environment or if deemed necessary by the board[198]. Financial Performance - The company's operating revenue for 2021 was CNY 4,048,445,944.19, representing a year-on-year increase of 48.80% compared to CNY 2,720,728,128.47 in 2020[20]. - The net profit attributable to shareholders for 2021 was CNY 536,168,573.50, a significant increase of 141.69% from CNY 221,845,912.48 in 2020[20]. - The net profit attributable to shareholders after deducting non-recurring gains and losses reached CNY 483,980,617.11, up 218.33% from CNY 152,036,673.13 in 2020[20]. - The net cash flow from operating activities decreased by 53.16% to CNY 243,488,177.90 from CNY 519,775,864.19 in 2020, primarily due to a significant increase in the prices of HFCs refrigerant products[21]. - The company's total assets at the end of 2021 were CNY 6,051,148,356.58, reflecting a 12.78% increase from CNY 5,365,526,243.35 at the end of 2020[20]. - The net assets attributable to shareholders increased by 6.14% to CNY 5,288,370,820.57 at the end of 2021 from CNY 4,982,218,202.57 at the end of 2020[20]. - Basic earnings per share for 2021 were CNY 0.88, a 144.44% increase compared to CNY 0.36 in 2020[21]. - The weighted average return on net assets for 2021 was 10.30%, an increase of 5.82 percentage points from 4.48% in 2020[21]. Risk Management - The company emphasizes the importance of risk awareness regarding forward-looking statements, which may differ significantly from actual future results[5]. - The company has detailed potential risks and corresponding countermeasures in the management discussion and analysis section of the report[6]. - The company has not reported any non-operational fund occupation by controlling shareholders or their affiliates[6]. - The company has not violated decision-making procedures in providing guarantees to external parties[6]. - The company maintains a commitment to transparency and accuracy in its financial reporting, as stated by its management[7]. Research and Development - The company holds 71 authorized patents, including 25 invention patents, with 3 invention patents and 11 utility model patents added during the reporting period[41]. - The company has initiated 32 R&D projects focusing on new refrigerants, foaming agents, and lithium battery materials, aligning with its strategic development plan[41]. - The company has invested in 32 R&D projects focusing on optimizing production processes and developing new products such as high-purity hydrogen fluoride and new refrigerants[111]. - The company employs a production model that integrates production, supply, and sales, allowing for timely adjustments based on market conditions[54]. Market and Industry Trends - The company is positioned in the chemical raw materials and products manufacturing industry, focusing on fluorinated refrigerants, foaming agents, and hydrogen fluoride[105]. - The company is actively extending its downstream industrial chain to utilize existing HCFCs capacity for non-ODS applications, ensuring sustainable development amid regulatory pressures[155]. - The company is committed to enhancing its environmental management practices and investing in pollution reduction technologies to comply with stricter regulations[148]. - The company is focusing on the development of new environmentally friendly refrigerants and foaming agents, as well as fluoropolymers and fluorochemicals to enhance its product portfolio and reduce cyclical risk exposure[150]. Corporate Governance - The company has established a performance evaluation system for senior management, linking compensation to performance and ensuring alignment with company growth[164]. - The company maintains independence from its controlling shareholders in terms of personnel, assets, finance, and operations, ensuring independent accounting and risk management[165]. - The company actively engages with investors through various communication channels, ensuring fair treatment of institutional and retail investors[166]. - The company emphasizes environmental protection and social responsibility, investing in clean production and community support initiatives[167]. Management and Personnel - The company has a management team with extensive experience in various sectors, including real estate and pharmaceuticals, indicating a diverse skill set[176]. - The current management includes individuals with significant tenure, such as Hu Qixiang, who has been with the company since 2012, showcasing stability in leadership[176]. - The company has a total of 1,722 employees, with 811 in the parent company and 911 in major subsidiaries[191]. - The professional composition includes 957 production personnel, 123 sales personnel, 210 technical personnel, 70 financial personnel, 185 administrative personnel, and 177 logistics personnel[191]. Regulatory Environment - The Ministry of Ecology and Environment announced a phased reduction plan for HCFCs, aiming for a 35% reduction by 2020 and a complete phase-out by 2030, excluding maintenance and special uses[95]. - The EU's F-gas regulation mandates a 55% reduction in HFCs by 2021-2023, with a target of 79% reduction by 2030[96]. - The Kigali Amendment to the Montreal Protocol, effective from January 1, 2019, sets a timeline for HFCs reduction, including a 10% reduction by 2019 and 85% by 2036 for developed countries[97]. - The Ministry of Ecology and Environment prohibits new projects for producing controlled ozone-depleting substances as refrigerants, foaming agents, and other uses[98].